(+)-taxifolin multiple interactions EXP 6480464 Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein]] more ... CTD PMID:35465754 (-)-cotinine increases expression EXP 6480464 Cotinine results in increased expression of MKI67 protein CTD PMID:31678612 (20S)-ginsenoside Rg3 multiple interactions ISO RGD:1313525 6480464 [ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein CTD PMID:31916386 (R,R,R)-alpha-tocopherol multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA CTD PMID:23859036 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of MKI67 protein CTD PMID:31678612 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of MKI67 protein CTD PMID:30959089 (S)-nicotine multiple interactions EXP 6480464 [Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein more ... CTD PMID:29501575 (Z)-3-butylidenephthalide decreases expression EXP 6480464 butylidenephthalide results in decreased expression of MKI67 protein CTD PMID:16987298 (Z)-3-butylidenephthalide decreases expression ISO RGD:1313525 6480464 butylidenephthalide results in decreased expression of MKI67 protein CTD PMID:16987298 1,1-dichloroethene increases expression ISO RGD:1313526 6480464 vinylidene chloride results in increased expression of MKI67 mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1313526 6480464 ethylene dichloride results in decreased expression of MKI67 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine multiple interactions EXP 6480464 Artesunate inhibits the reaction [1 more ... CTD PMID:29031619 more ... 1,2-dimethylhydrazine increases expression ISO RGD:1313526 6480464 1, 2-Dimethylhydrazine results in increased expression of MKI67 mRNA CTD PMID:22206623 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of MKI67 protein CTD PMID:29031619 more ... 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:1313526 6480464 Dinitrochlorobenzene affects the expression of MKI67 mRNA CTD PMID:22302311 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:1313525 6480464 Dinitrochlorobenzene binds to MKI67 protein CTD PMID:32991956 1-methyltryptophan multiple interactions ISO RGD:1313525 6480464 1-methyltryptophan inhibits the reaction [indeno(1 more ... CTD PMID:35687267 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of MKI67 mRNA, 1-Naphthylisothiocyanate results in increased expression of MKI67 protein CTD PMID:23411599 , PMID:30723492 1-naphthyl isothiocyanate affects expression EXP 6480464 1-Naphthylisothiocyanate affects the expression of MKI67 protein CTD PMID:26011634 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MKI67 mRNA CTD PMID:17351261 17beta-estradiol increases expression ISO RGD:1313526 6480464 Estradiol deficiency results in increased expression of MKI67 protein, Estradiol results in increased expression of MKI67 protein CTD PMID:15845746 more ... 17beta-estradiol increases expression ISO RGD:1313525 6480464 Estradiol results in increased expression of MKI67 mRNA CTD PMID:18310284 more ... 17beta-estradiol multiple interactions ISO RGD:1313525 6480464 [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA, Fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA] CTD PMID:27260121 , PMID:33047385 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of MKI67 mRNA, Estradiol results in increased expression of MKI67 protein CTD PMID:16607101 more ... 17beta-estradiol multiple interactions EXP 6480464 9 more ... CTD PMID:16891317 more ... 17beta-estradiol multiple interactions ISO RGD:1313526 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of MKI67 protein] more ... CTD PMID:15845746 more ... 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA CTD PMID:32741896 1H-pyrazole decreases expression ISO RGD:1313526 6480464 pyrazole results in decreased expression of MKI67 protein CTD PMID:33737021 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1313526 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1313525 6480464 2 more ... CTD PMID:31173147 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO RGD:1313525 6480464 [2 more ... CTD PMID:30796839 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1313526 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1313526 6480464 Tetrachlorodibenzodioxin results in increased expression of MKI67 mRNA CTD PMID:21846477 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313526 6480464 Tetrachlorodibenzodioxin results in decreased expression of MKI67 protein CTD PMID:32283119 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MKI67 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313526 6480464 Tetrachlorodibenzodioxin affects the expression of MKI67 mRNA CTD PMID:18691609 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313526 6480464 Tetrachlorodibenzodioxin promotes the reaction [NFE2L2 gene mutant form results in increased expression of MKI67 protein] CTD PMID:21846477 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1313526 6480464 Trinitrobenzenesulfonic Acid results in increased expression of MKI67 mRNA CTD PMID:17982090 2-acetamidofluorene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein more ... CTD PMID:15565650 more ... 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of MKI67 protein CTD PMID:15565650 more ... 2-acetamidofluorene increases expression ISO RGD:1313526 6480464 2-Acetylaminofluorene results in increased expression of MKI67 mRNA CTD PMID:17317680 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of MKI67 mRNA CTD PMID:17109745 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:1313526 6480464 U 0126 inhibits the reaction [Triiodothyronine results in increased expression of MKI67 mRNA] CTD PMID:28315333 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1313526 6480464 Triiodothyronine results in increased expression of MKI67 mRNA CTD PMID:28315333 3-methylcholanthrene increases expression ISO RGD:1313526 6480464 Methylcholanthrene results in increased expression of MKI67 mRNA CTD PMID:20713471 3-methylcholanthrene multiple interactions EXP 6480464 Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA], Methylcholanthrene inhibits the reaction [Estradiol results in increased expression of MKI67 protein] CTD PMID:26372666 3-nitropropanoic acid decreases expression EXP 6480464 3-nitropropionic acid results in decreased expression of MKI67 protein CTD PMID:21827787 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of MKI67 mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol affects expression ISO RGD:1313526 6480464 bis(4-hydroxyphenyl)sulfone affects the expression of MKI67 protein CTD PMID:29526645 4,4'-sulfonyldiphenol increases expression ISO RGD:1313525 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of MKI67 protein CTD PMID:31945527 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO RGD:1313525 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of MKI67 protein CTD PMID:21776270 4-Hydroxybenzophenone multiple interactions ISO RGD:1313526 6480464 CXCL1 protein promotes the reaction [4-hydroxybenzophenone results in decreased expression of MKI67 protein] CTD PMID:35476924 4-Hydroxybenzophenone decreases expression ISO RGD:1313526 6480464 4-hydroxybenzophenone results in decreased expression of MKI67 protein CTD PMID:35476924 4-hydroxynon-2-enal decreases expression ISO RGD:1313526 6480464 4-hydroxy-2-nonenal results in decreased expression of MKI67 mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide increases expression ISO RGD:1313526 6480464 Fenretinide results in increased expression of MKI67 mRNA CTD PMID:28973697 5'-S-methyl-5'-thioadenosine decreases expression ISO RGD:1313526 153297773 5'-S-methyl-5'-thioadenosine decreases expression of Ki-67 protein in Mdr2-/- mouse liver RGD 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 Decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein] CTD PMID:22457795 5-azacytidine multiple interactions ISO RGD:1313525 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA CTD PMID:18720364 5-fluorouracil affects response to substance ISO RGD:1313525 6480464 MKI67 mRNA affects the susceptibility to Fluorouracil, MKI67 protein affects the susceptibility to Fluorouracil CTD PMID:15548681 , PMID:18286688 5-fluorouracil decreases expression ISO RGD:1313525 6480464 Fluorouracil results in decreased expression of MKI67, Fluorouracil results in decreased expression of MKI67 mRNA CTD PMID:11300326 more ... 6-propyl-2-thiouracil multiple interactions EXP 6480464 [diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein more ... CTD PMID:19497425 7,12-dimethyltetraphene multiple interactions EXP 6480464 9 more ... CTD PMID:16891317 more ... 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:34896434 ABT-737 decreases expression ISO RGD:1313525 6480464 ABT-737 results in decreased expression of MKI67 protein CTD PMID:19773376 ABT-737 multiple interactions ISO RGD:1313525 6480464 [ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein CTD PMID:19773376 acetamide increases expression EXP 6480464 acetamide results in increased expression of MKI67 mRNA, acetamide results in increased expression of MKI67 protein CTD PMID:31881176 acetamiprid decreases expression ISO RGD:1313526 6480464 acetamiprid results in decreased expression of MKI67 mRNA CTD PMID:30103633 acetylsalicylic acid multiple interactions EXP 6480464 Aspirin inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of MKI67 protein] CTD PMID:29031619 acrolein multiple interactions ISO RGD:1313525 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:1313525 6480464 Acrylamide results in decreased expression of MKI67 mRNA, Acrylamide results in decreased expression of MKI67 protein CTD PMID:20734998 , PMID:32763439 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of MKI67 mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1313525 6480464 Aflatoxin B1 affects the expression of MKI67 protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of MKI67 mRNA CTD PMID:25378103 aflatoxin B1 decreases expression ISO RGD:1313525 6480464 Aflatoxin B1 results in decreased expression of MKI67 mRNA CTD PMID:21641981 aflatoxin B1 decreases expression ISO RGD:1313526 6480464 Aflatoxin B1 results in decreased expression of MKI67 mRNA CTD PMID:19770486 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of MKI67 mRNA CTD PMID:17109745 aldehydo-D-glucose multiple interactions ISO RGD:1313525 6480464 [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA more ... CTD PMID:25192544 all-trans-retinoic acid decreases expression ISO RGD:1313525 6480464 Tretinoin results in decreased expression of MKI67 mRNA, Tretinoin results in decreased expression of MKI67 protein CTD PMID:16249480 more ... all-trans-retinoic acid multiple interactions EXP 6480464 Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein] CTD PMID:21964460 alpha-hexylcinnamaldehyde affects expression ISO RGD:1313526 6480464 hexyl cinnamic aldehyde affects the expression of MKI67 mRNA CTD PMID:22302311 alpha-pinene multiple interactions ISO RGD:1313525 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of MKI67 mRNA CTD PMID:32699268 aminoguanidine decreases expression ISO RGD:1313525 6480464 pimagedine results in decreased expression of MKI67 mRNA CTD PMID:19266598 anastrozole multiple interactions ISO RGD:1313525 6480464 [Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein CTD PMID:15767642 anastrozole decreases expression ISO RGD:1313525 6480464 anastrozole results in decreased expression of MKI67 protein CTD PMID:15767642 , PMID:16002280 aniline increases expression EXP 6480464 aniline results in increased expression of MKI67 protein CTD PMID:21070798 antimycin A increases expression ISO RGD:1313525 6480464 Antimycin A results in increased expression of MKI67 mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO RGD:1313525 6480464 Antirheumatic Agents results in decreased expression of MKI67 mRNA CTD PMID:24449571 Aroclor 1254 multiple interactions EXP 6480464 Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein] CTD PMID:33592256 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein CTD PMID:33592256 arsane multiple interactions ISO RGD:1313525 6480464 [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA CTD PMID:33047385 arsenic atom multiple interactions ISO RGD:1313525 6480464 [Arsenic co-treated with Estradiol] results in increased expression of MKI67 mRNA CTD PMID:33047385 arsenite(3-) multiple interactions ISO RGD:1313525 6480464 arsenite inhibits the reaction [G3BP1 protein binds to MKI67 mRNA] CTD PMID:32406909 arsenous acid multiple interactions ISO RGD:1313526 6480464 FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein] CTD PMID:31421153 arsenous acid multiple interactions ISO RGD:1313525 6480464 3-(2, 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA] CTD PMID:27318970 arsenous acid decreases expression ISO RGD:1313525 6480464 Arsenic Trioxide results in decreased expression of MKI67 mRNA, Arsenic Trioxide results in decreased expression of MKI67 protein CTD PMID:27318970 , PMID:30091188 arsenous acid decreases expression ISO RGD:1313526 6480464 Arsenic Trioxide results in decreased expression of MKI67 protein CTD PMID:31421153 artesunate multiple interactions EXP 6480464 artesunate inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of MKI67 protein] CTD PMID:29031619 atrazine multiple interactions ISO RGD:1313525 6480464 [Atrazine co-treated with Arsenates] results in increased expression of MKI67 mRNA CTD PMID:18585445 atrazine decreases expression ISO RGD:1313525 6480464 Atrazine results in decreased expression of MKI67 mRNA CTD PMID:34146662 azathioprine decreases expression ISO RGD:1313525 6480464 Azathioprine results in decreased expression of MKI67 mRNA CTD PMID:22623647 benzene decreases expression ISO RGD:1313525 6480464 Benzene results in decreased expression of MKI67 mRNA CTD PMID:21843810 benzo[a]pyrene increases expression ISO RGD:1313526 6480464 Benzo(a)pyrene results in increased expression of MKI67 mRNA CTD PMID:20713471 , PMID:32417428 benzo[a]pyrene multiple interactions ISO RGD:1313526 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA CTD PMID:27858113 benzo[a]pyrene decreases expression ISO RGD:1313526 6480464 Benzo(a)pyrene results in decreased expression of MKI67 mRNA CTD PMID:17942131 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1313525 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO RGD:1313525 6480464 benzo(b)fluoranthene results in increased expression of MKI67 protein CTD PMID:21776270 benzo[b]fluoranthene multiple interactions ISO RGD:1313526 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA CTD PMID:27858113 benzo[b]fluoranthene increases expression ISO RGD:1313526 6480464 benzo(b)fluoranthene results in increased expression of MKI67 mRNA CTD PMID:26377693 Benzo[ghi]perylene increases expression ISO RGD:1313525 6480464 1, 12-benzoperylene results in increased expression of MKI67 protein CTD PMID:31518672 Benzo[ghi]perylene decreases expression ISO RGD:1313525 6480464 1, 12-benzoperylene results in decreased expression of MKI67 protein CTD PMID:35182551 Benzo[ghi]perylene multiple interactions ISO RGD:1313525 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1 more ... CTD PMID:31518672 , PMID:35182551 benzoates decreases expression ISO RGD:1313525 6480464 Benzoates analog results in decreased expression of MKI67 protein CTD PMID:29472718 beta-carotene multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA CTD PMID:23859036 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of MKI67 mRNA CTD PMID:17109745 betulin multiple interactions ISO RGD:1313525 6480464 [Gefitinib co-treated with betulin] results in decreased expression of MKI67 protein CTD PMID:27447558 bicalutamide decreases expression ISO RGD:1313525 6480464 bicalutamide results in decreased expression of MKI67 mRNA CTD PMID:15638997 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1313526 6480464 Diethylhexyl Phthalate results in increased expression of MKI67 mRNA CTD PMID:24496636 bisphenol A increases expression ISO RGD:1313526 6480464 bisphenol A results in increased expression of MKI67 mRNA, bisphenol A results in increased expression of MKI67 protein CTD PMID:22875908 bisphenol A multiple interactions EXP 6480464 Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein] more ... CTD PMID:35465754 bisphenol A decreases expression ISO RGD:1313526 6480464 bisphenol A results in decreased expression of MKI67 protein CTD PMID:35278557 bisphenol A affects expression ISO RGD:1313525 6480464 bisphenol A affects the expression of MKI67 mRNA CTD PMID:30903817 bisphenol A multiple interactions ISO RGD:1313525 6480464 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of MKI67 mRNA] CTD PMID:28701262 bisphenol A decreases expression ISO RGD:1313525 6480464 bisphenol A results in decreased expression of MKI67 mRNA CTD PMID:28701262 , PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of MKI67 mRNA CTD PMID:23146694 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MKI67 protein CTD PMID:26877094 , PMID:35465754 bisphenol F decreases expression ISO RGD:1313526 6480464 bisphenol F results in decreased expression of MKI67 protein CTD PMID:35278557 bortezomib decreases expression ISO RGD:1313525 6480464 Bortezomib results in decreased expression of MKI67 protein CTD PMID:19372569 bortezomib multiple interactions ISO RGD:1313526 6480464 [Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein more ... CTD PMID:30482226 bucladesine decreases expression EXP 6480464 Bucladesine results in decreased expression of MKI67 protein CTD PMID:16718685 butanal decreases expression ISO RGD:1313525 6480464 butyraldehyde results in decreased expression of MKI67 mRNA CTD PMID:26079696 butylated hydroxyanisole increases expression EXP 6480464 Butylated Hydroxyanisole results in increased expression of MKI67 protein CTD PMID:23535288 butylated hydroxyanisole decreases expression EXP 6480464 Butylated Hydroxyanisole results in decreased expression of MKI67 protein CTD PMID:23535288 cadmium atom decreases expression ISO RGD:1313525 6480464 Cadmium results in decreased expression of MKI67 mRNA CTD PMID:21120746 cadmium atom multiple interactions ISO RGD:1313525 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 mRNA CTD PMID:29741670 cadmium dichloride multiple interactions EXP 6480464 decitabine inhibits the reaction [Cadmium Chloride results in increased expression of MKI67 protein] CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:1313525 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of MKI67 mRNA CTD PMID:29741670 cadmium dichloride increases expression ISO RGD:1313525 6480464 Cadmium Chloride results in increased expression of MKI67 mRNA CTD PMID:26472689 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of MKI67 mRNA, Cadmium Chloride results in decreased expression of MKI67 protein CTD PMID:25993096 , PMID:30506660 cadmium dichloride decreases expression ISO RGD:1313526 6480464 Cadmium Chloride results in decreased expression of MKI67 mRNA CTD PMID:24982889 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of MKI67 protein CTD PMID:22081424 , PMID:22457795 caffeine multiple interactions EXP 6480464 Caffeine inhibits the reaction [aluminum chloride results in decreased expression of MKI67 protein] CTD PMID:26339337 caffeine affects phosphorylation ISO RGD:1313525 6480464 Caffeine affects the phosphorylation of MKI67 protein CTD PMID:35688186 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of MKI67 protein CTD PMID:30528684 calcitriol decreases expression ISO RGD:1313525 6480464 Calcitriol results in decreased expression of MKI67 mRNA, Calcitriol results in decreased expression of MKI67 protein CTD PMID:21592394 , PMID:8950452 calcitriol multiple interactions ISO RGD:1313525 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA CTD PMID:21592394 camostat increases expression ISO RGD:1313526 6480464 camostat results in increased expression of MKI67 protein CTD PMID:25104499 camostat multiple interactions ISO RGD:1313526 6480464 mirdametinib inhibits the reaction [camostat results in increased expression of MKI67 protein] CTD PMID:25104499 cannabidiol decreases expression ISO RGD:1313526 6480464 Cannabidiol results in decreased expression of MKI67 protein CTD PMID:24910342 capsaicin multiple interactions EXP 6480464 Capsaicin inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of MKI67 protein] CTD PMID:29155087 Carbadox decreases expression EXP 6480464 Carbadox results in decreased expression of MKI67 protein CTD PMID:26558467 carbamazepine affects expression ISO RGD:1313525 6480464 Carbamazepine affects the expression of MKI67 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1313526 6480464 Nanotubes more ... CTD PMID:25554681 catechol increases expression EXP 6480464 catechol results in increased expression of MKI67 protein CTD PMID:23535288 catechol decreases expression EXP 6480464 catechol results in decreased expression of MKI67 protein CTD PMID:23535288 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of MKI67 mRNA CTD PMID:18500788 celecoxib decreases expression ISO RGD:1313525 6480464 Celecoxib results in decreased expression of MKI67 CTD PMID:20697803 celecoxib multiple interactions ISO RGD:1313526 6480464 Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein] CTD PMID:32416088 celecoxib multiple interactions ISO RGD:1313525 6480464 [FEC protocol co-treated with Celecoxib] results in decreased expression of MKI67 protein CTD PMID:16507397 chlorohydrocarbon multiple interactions ISO RGD:1313525 6480464 [Hydrocarbons more ... CTD PMID:33333158 chloroquine multiple interactions ISO RGD:1313526 6480464 [Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein more ... CTD PMID:30482226 chloroquine multiple interactions ISO RGD:1313525 6480464 [Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein CTD PMID:30025493 chlorpromazine decreases expression ISO RGD:1313525 6480464 Chlorpromazine analog results in decreased expression of MKI67 mRNA CTD PMID:15924885 cholesterol multiple interactions ISO RGD:1313525 6480464 [[[EGF protein binds to 1 more ... CTD PMID:35385781 choline multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA CTD PMID:20938992 , PMID:33549593 chrysene multiple interactions ISO RGD:1313526 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA CTD PMID:27858113 ciglitazone multiple interactions ISO RGD:1313525 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of MKI67 mRNA CTD PMID:16197558 cisplatin multiple interactions ISO RGD:1313525 6480464 [Cisplatin co-treated with Quercetin] results in decreased expression of MKI67 protein CTD PMID:16082193 cisplatin decreases expression ISO RGD:1313525 6480464 Cisplatin results in decreased expression of MKI67 mRNA CTD PMID:27594783 cisplatin increases expression ISO RGD:1313526 6480464 Cisplatin results in increased expression of MKI67 protein CTD PMID:20702592 cisplatin increases phosphorylation ISO RGD:1313526 6480464 Cisplatin results in increased phosphorylation of MKI67 protein CTD PMID:22006019 clobetasol decreases expression ISO RGD:1313526 6480464 Clobetasol results in decreased expression of MKI67 mRNA CTD PMID:27462272 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of MKI67 mRNA CTD PMID:32741897 cobalt dichloride multiple interactions ISO RGD:1313525 6480464 [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA more ... CTD PMID:25192544 cobalt dichloride decreases expression ISO RGD:1313525 6480464 cobaltous chloride results in decreased expression of MKI67 mRNA CTD PMID:19320972 , PMID:19376846 copper atom multiple interactions EXP 6480464 Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein], Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein] CTD PMID:19497425 copper atom decreases expression ISO RGD:1313525 6480464 Copper results in decreased expression of MKI67 protein CTD PMID:32004626 copper atom increases expression EXP 6480464 Copper results in increased expression of MKI67 mRNA CTD PMID:30556269 copper atom decreases expression ISO RGD:1313526 6480464 Copper deficiency results in decreased expression of MKI67 protein CTD PMID:24013775 copper atom multiple interactions ISO RGD:1313525 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA, Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein] CTD PMID:20971185 , PMID:32004626 copper(0) multiple interactions EXP 6480464 Copper deficiency inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein], Copper inhibits the reaction [[diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein] CTD PMID:19497425 copper(0) increases expression EXP 6480464 Copper results in increased expression of MKI67 mRNA CTD PMID:30556269 copper(0) decreases expression ISO RGD:1313525 6480464 Copper results in decreased expression of MKI67 protein CTD PMID:32004626 copper(0) decreases expression ISO RGD:1313526 6480464 Copper deficiency results in decreased expression of MKI67 protein CTD PMID:24013775 copper(0) multiple interactions ISO RGD:1313525 6480464 [NSC 689534 binds to Copper] which results in decreased expression of MKI67 mRNA, Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein] CTD PMID:20971185 , PMID:32004626 copper(II) sulfate affects expression ISO RGD:1313525 6480464 Copper Sulfate affects the expression of MKI67 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:1313525 6480464 coumarin affects the phosphorylation of MKI67 protein CTD PMID:35688186 coumestrol increases expression ISO RGD:1313525 6480464 Coumestrol results in increased expression of MKI67 mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:1313525 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 , PMID:19167446 crocidolite asbestos increases expression ISO RGD:1313526 6480464 Asbestos, Crocidolite results in increased expression of MKI67 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of MKI67 mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:1313526 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein CTD PMID:17440100 curcumin decreases expression ISO RGD:1313525 6480464 Curcumin results in decreased expression of MKI67 protein CTD PMID:18226269 , PMID:19372569 cyanocob(III)alamin multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA CTD PMID:33549593 cyclohexanols multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Cyclohexanols] results in increased expression of MKI67 protein CTD PMID:17393424 Cyclopamine decreases expression ISO RGD:1313526 6480464 cyclopamine results in decreased expression of MKI67 protein CTD PMID:22923130 cyclophosphamide decreases expression ISO RGD:1313526 6480464 Cyclophosphamide results in decreased expression of MKI67 protein CTD PMID:33737021 cyclosporin A decreases expression ISO RGD:1313526 6480464 Cyclosporine results in decreased expression of MKI67 mRNA CTD PMID:17942131 , PMID:19770486 cyclosporin A decreases expression ISO RGD:1313525 6480464 Cyclosporine results in decreased expression of MKI67 mRNA CTD PMID:19159671 more ... cyclosporin A affects expression EXP 6480464 Cyclosporine affects the expression of MKI67 mRNA CTD PMID:24971338 cypermethrin decreases expression ISO RGD:1313525 6480464 cypermethrin results in decreased expression of MKI67 protein CTD PMID:36063984 cyproconazole increases expression ISO RGD:1313526 6480464 cyproconazole results in increased expression of MKI67 protein CTD PMID:22334560 D-glucose multiple interactions ISO RGD:1313525 6480464 [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA more ... CTD PMID:25192544 decabromodiphenyl ether decreases expression ISO RGD:1313525 6480464 decabromobiphenyl ether results in decreased expression of MKI67 protein CTD PMID:26206603 deguelin decreases expression ISO RGD:1313525 6480464 deguelin results in decreased expression of MKI67 protein CTD PMID:22623043 deoxynivalenol multiple interactions ISO RGD:1313526 6480464 Celecoxib inhibits the reaction [deoxynivalenol results in increased expression of MKI67 protein] CTD PMID:32416088 deoxynivalenol increases expression ISO RGD:1313526 6480464 deoxynivalenol results in increased expression of MKI67 protein CTD PMID:32416088 deoxynivalenol increases expression ISO RGD:1313525 6480464 deoxynivalenol results in increased expression of MKI67 mRNA CTD PMID:31863870 deoxynivalenol increases phosphorylation ISO RGD:1313526 6480464 deoxynivalenol results in increased phosphorylation of MKI67 protein CTD PMID:23352502 , PMID:23811945 dexamethasone decreases expression ISO RGD:1313525 6480464 Dexamethasone results in decreased expression of MKI67 protein CTD PMID:22048647 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of MKI67 protein CTD PMID:29111458 dextran sulfate multiple interactions EXP 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein, Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein] CTD PMID:19028472 dextran sulfate multiple interactions ISO RGD:1313526 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein CTD PMID:34273909 diarsenic trioxide decreases expression ISO RGD:1313526 6480464 Arsenic Trioxide results in decreased expression of MKI67 protein CTD PMID:31421153 diarsenic trioxide decreases expression ISO RGD:1313525 6480464 Arsenic Trioxide results in decreased expression of MKI67 mRNA, Arsenic Trioxide results in decreased expression of MKI67 protein CTD PMID:27318970 , PMID:30091188 diarsenic trioxide multiple interactions ISO RGD:1313525 6480464 3-(2, 4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3H)-quinazolinone inhibits the reaction [Arsenic Trioxide results in decreased expression of MKI67 mRNA] CTD PMID:27318970 diarsenic trioxide multiple interactions ISO RGD:1313526 6480464 FOXO3 protein affects the reaction [Arsenic Trioxide results in decreased expression of MKI67 protein] CTD PMID:31421153 diazinon affects expression EXP 6480464 Diazinon affects the expression of MKI67 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:1313526 6480464 1 more ... CTD PMID:26377693 dibenzo[a,l]pyrene decreases expression ISO RGD:1313525 6480464 dibenzo(a, l)pyrene results in decreased expression of MKI67 mRNA CTD PMID:16269432 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of MKI67 mRNA CTD PMID:21266533 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of MKI67 protein CTD PMID:16916955 dicrotophos increases expression ISO RGD:1313525 6480464 dicrotophos results in increased expression of MKI67 mRNA CTD PMID:28302478 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of MKI67 mRNA CTD PMID:22546817 diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of MKI67 mRNA CTD PMID:21161181 diethylstilbestrol increases expression ISO RGD:1313526 6480464 Diethylstilbestrol results in increased expression of MKI67 protein CTD PMID:16468032 diisononyl phthalate increases expression ISO RGD:1313526 6480464 diisononyl phthalate results in increased expression of MKI67 protein CTD PMID:34453847 Dimefox increases expression ISO RGD:1313525 6480464 dimefox results in increased expression of MKI67 protein CTD PMID:18418871 diosmin multiple interactions EXP 6480464 Diosmin inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein], Diosmin inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein] CTD PMID:23665045 dioxygen multiple interactions ISO RGD:1313526 6480464 Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of MKI67 mRNA] CTD PMID:22629407 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of MKI67 mRNA CTD PMID:33729688 dioxygen increases expression ISO RGD:1313526 6480464 Oxygen deficiency results in increased expression of MKI67 mRNA CTD PMID:22629407 , PMID:24205000 disodium selenite decreases expression ISO RGD:1313525 6480464 Sodium Selenite results in decreased expression of MKI67 mRNA CTD PMID:24383545 disodium selenite multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA CTD PMID:23859036 dorsomorphin multiple interactions ISO RGD:1313525 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1313525 6480464 Doxorubicin results in decreased expression of MKI67 mRNA CTD PMID:15205334 more ... doxorubicin multiple interactions ISO RGD:1313526 6480464 Doxorubicin promotes the reaction [CEBPB protein alternative form promotes the reaction [[Chloroquine co-treated with Bortezomib] results in increased expression of MKI67 protein]] CTD PMID:30482226 doxorubicin multiple interactions ISO RGD:1313525 6480464 [zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein, Doxorubicin promotes the reaction [palbociclib results in decreased expression of MKI67 protein] CTD PMID:18695136 , PMID:22751436 Echimidine increases expression EXP 6480464 echimidine results in increased expression of MKI67 mRNA CTD PMID:32419051 embelin decreases expression ISO RGD:1313525 6480464 embelin results in decreased expression of MKI67 protein CTD PMID:24694877 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of MKI67 protein CTD PMID:28935589 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MKI67 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO RGD:1313525 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MKI67 mRNA CTD PMID:19167446 entinostat decreases expression ISO RGD:1313526 6480464 entinostat results in decreased expression of MKI67 protein CTD PMID:21041383 enzalutamide multiple interactions ISO RGD:1313525 6480464 enzalutamide promotes the reaction [NVP-BHG712 results in decreased expression of MKI67 protein] CTD PMID:32184358 enzyme inhibitor multiple interactions ISO RGD:1313525 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of MKI67 protein CTD PMID:23301498 epoxiconazole increases expression ISO RGD:1313526 6480464 epoxiconazole results in increased expression of MKI67 protein CTD PMID:22334560 erastin decreases expression ISO RGD:1313525 6480464 erastin results in decreased expression of MKI67 protein CTD PMID:35234341 erastin multiple interactions ISO RGD:1313525 6480464 BGN mRNA alternative form inhibits the reaction [erastin results in decreased expression of MKI67 protein] CTD PMID:35234341 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of MKI67 protein CTD PMID:17067360 more ... ethanol increases expression EXP 6480464 Ethanol results in increased expression of MKI67 protein CTD PMID:29769550 ethanol multiple interactions ISO RGD:1313525 6480464 IGF1 protein inhibits the reaction [Ethanol results in decreased expression of MKI67 protein] CTD PMID:31226463 ethanol decreases expression ISO RGD:1313525 6480464 Ethanol results in decreased expression of MKI67 protein CTD PMID:31226463 exemestane decreases expression ISO RGD:1313525 6480464 exemestane results in decreased expression of MKI67 protein CTD PMID:16002280 fenbendazole increases expression EXP 6480464 Fenbendazole results in increased expression of MKI67 protein CTD PMID:23411599 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of MKI67 mRNA, Fenofibrate results in increased expression of MKI67 protein CTD PMID:17264098 , PMID:32741897 fenpyroximate increases expression ISO RGD:1313525 6480464 fenpyroximate results in increased expression of MKI67 mRNA CTD PMID:33512557 fenthion decreases expression ISO RGD:1313526 6480464 Fenthion results in decreased expression of MKI67 protein CTD PMID:34813904 flavokawain B multiple interactions ISO RGD:1313525 6480464 [ATG5 protein affects the susceptibility to flavokawain B] which affects the expression of MKI67 protein, [Chloroquine co-treated with flavokawain B] results in decreased expression of MKI67 protein CTD PMID:30025493 flutamide increases expression EXP 6480464 Flutamide results in increased expression of MKI67 protein CTD PMID:26485406 fluvastatin multiple interactions EXP 6480464 Fluvastatin inhibits the reaction [bisphenol A results in increased expression of MKI67 protein] more ... CTD PMID:35465754 folic acid multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA CTD PMID:20938992 , PMID:33549593 folic acid affects expression ISO RGD:1313525 6480464 Folic Acid affects the expression of MKI67 protein CTD PMID:21349824 fulvestrant multiple interactions ISO RGD:1313526 6480464 fulvestrant inhibits the reaction [1 more ... CTD PMID:19654927 fulvestrant multiple interactions ISO RGD:1313525 6480464 fulvestrant inhibits the reaction [bisphenol A results in decreased expression of MKI67 mRNA] more ... CTD PMID:27260121 , PMID:28701262 furan increases expression EXP 6480464 furan results in increased expression of MKI67 mRNA, furan results in increased expression of MKI67 protein CTD PMID:20562052 more ... gefitinib multiple interactions ISO RGD:1313525 6480464 [Gefitinib co-treated with betulin] results in decreased expression of MKI67 protein CTD PMID:27447558 gemcitabine multiple interactions ISO RGD:1313526 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of MKI67 protein CTD PMID:17440100 genistein multiple interactions EXP 6480464 Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA] CTD PMID:20381596 genistein decreases expression ISO RGD:1313526 6480464 Genistein results in decreased expression of MKI67 mRNA CTD PMID:31593742 genistein increases expression EXP 6480464 Genistein results in increased expression of MKI67 mRNA CTD PMID:20381596 geraniol decreases expression ISO RGD:1313525 6480464 geraniol results in decreased expression of MKI67 mRNA CTD PMID:27683099 geraniol decreases expression ISO RGD:1313526 6480464 geraniol results in decreased expression of MKI67 protein CTD PMID:26154255 glucose multiple interactions ISO RGD:1313525 6480464 [cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA more ... CTD PMID:25192544 glycine betaine multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA CTD PMID:33549593 glyphosate increases expression EXP 6480464 glyphosate results in increased expression of MKI67 protein CTD PMID:27486271 gold atom multiple interactions ISO RGD:1313525 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA CTD PMID:28433809 gold atom decreases expression ISO RGD:1313525 6480464 Gold analog results in decreased expression of MKI67 mRNA CTD PMID:36057382 gold(0) multiple interactions ISO RGD:1313525 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of MKI67 mRNA CTD PMID:28433809 gold(0) decreases expression ISO RGD:1313525 6480464 Gold analog results in decreased expression of MKI67 mRNA CTD PMID:36057382 harmaline decreases expression ISO RGD:1313526 6480464 Harmaline results in decreased expression of MKI67 protein CTD PMID:35963316 Heliotrine increases expression EXP 6480464 heliotrine results in increased expression of MKI67 mRNA CTD PMID:32419051 hexadecanoic acid increases phosphorylation ISO RGD:1313525 6480464 Palmitic Acid results in increased phosphorylation of MKI67 protein CTD PMID:28073184 Hexamethonium multiple interactions EXP 6480464 Hexamethonium inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein] CTD PMID:29501575 hydroquinone O-beta-D-glucopyranoside increases expression ISO RGD:1313525 6480464 Arbutin results in increased expression of MKI67 mRNA CTD PMID:17103032 icariside II decreases expression ISO RGD:1313525 6480464 baohuoside I results in decreased expression of MKI67 protein CTD PMID:25119583 Indeno[1,2,3-cd]pyrene increases expression ISO RGD:1313525 6480464 indeno(1 more ... CTD PMID:35687267 Indeno[1,2,3-cd]pyrene multiple interactions ISO RGD:1313525 6480464 1-methyltryptophan inhibits the reaction [indeno(1 more ... CTD PMID:35687267 indometacin multiple interactions EXP 6480464 Indomethacin inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein], Indomethacin inhibits the reaction [Sulfadimethoxine results in increased expression of MKI67 protein] CTD PMID:22387750 iodoacetic acid decreases expression ISO RGD:1313526 6480464 Iodoacetic Acid results in decreased expression of MKI67 mRNA CTD PMID:31693920 irinotecan multiple interactions ISO RGD:1313525 6480464 [Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein CTD PMID:30612311 isoflavones multiple interactions EXP 6480464 Isoflavones inhibits the reaction [Estradiol results in increased expression of MKI67 mRNA], Isoflavones inhibits the reaction [Genistein results in increased expression of MKI67 mRNA] CTD PMID:20381596 , PMID:23288143 isoflavones increases expression EXP 6480464 Isoflavones results in increased expression of MKI67 mRNA CTD PMID:23288143 isoflavones decreases expression EXP 6480464 Isoflavones results in decreased expression of MKI67 mRNA CTD PMID:23288143 isoliquiritigenin decreases expression ISO RGD:1313526 6480464 isoliquiritigenin results in decreased expression of MKI67 mRNA, isoliquiritigenin results in decreased expression of MKI67 protein CTD PMID:27702603 ivermectin decreases expression ISO RGD:1313525 6480464 Ivermectin results in decreased expression of MKI67 protein CTD PMID:32959892 ketamine increases expression ISO RGD:1313525 6480464 Ketamine results in increased expression of MKI67 protein CTD PMID:19919587 ketoconazole increases expression ISO RGD:1313526 6480464 Ketoconazole results in increased expression of MKI67 mRNA CTD PMID:25808816 L-ascorbic acid multiple interactions ISO RGD:1313525 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA CTD PMID:17639512 L-ascorbic acid multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA CTD PMID:23859036 L-methionine multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of MKI67 mRNA CTD PMID:20938992 , PMID:33549593 lead diacetate multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein, Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein] CTD PMID:33978298 lead(0) multiple interactions ISO RGD:1313525 6480464 Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein] CTD PMID:32004626 lead(0) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein, Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein] CTD PMID:33978298 lead(0) decreases expression ISO RGD:1313525 6480464 Lead results in decreased expression of MKI67 protein CTD PMID:32004626 lead(0) affects expression ISO RGD:1313525 6480464 Lead affects the expression of MKI67 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1313525 6480464 Lead affects the expression of MKI67 mRNA CTD PMID:28903495 lead(2+) multiple interactions EXP 6480464 [lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein, Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein] CTD PMID:33978298 lead(2+) decreases expression ISO RGD:1313525 6480464 Lead results in decreased expression of MKI67 protein CTD PMID:32004626 lead(2+) multiple interactions ISO RGD:1313525 6480464 Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein] CTD PMID:32004626 leflunomide decreases expression ISO RGD:1313525 6480464 leflunomide results in decreased expression of MKI67 mRNA CTD PMID:28988120 letrozole decreases expression ISO RGD:1313525 6480464 letrozole results in decreased expression of MKI67 protein CTD PMID:16002280 Leucomalachite green decreases expression EXP 6480464 leucomalachite green results in decreased expression of MKI67 protein CTD PMID:26558467 levonorgestrel decreases expression ISO RGD:1313525 6480464 Levonorgestrel results in decreased expression of MKI67 protein CTD PMID:16019350 lignan decreases expression ISO RGD:1313525 6480464 Lignans results in decreased expression of MKI67 protein CTD PMID:15897583 linezolid decreases expression EXP 6480464 Linezolid results in decreased expression of MKI67 mRNA CTD PMID:21296123 lithium atom increases expression EXP 6480464 Lithium results in increased expression of MKI67 mRNA CTD PMID:21711903 lithium chloride multiple interactions ISO RGD:1313526 6480464 Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]] CTD PMID:15845746 lithium hydride increases expression EXP 6480464 Lithium results in increased expression of MKI67 mRNA CTD PMID:21711903 lucanthone decreases expression ISO RGD:1313525 6480464 Lucanthone results in decreased expression of MKI67 mRNA CTD PMID:21148553 lupeol decreases expression ISO RGD:1313526 6480464 lupeol results in decreased expression of MKI67 mRNA CTD PMID:20732907 LY294002 multiple interactions ISO RGD:1313525 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [ANGPT2 protein results in increased expression of MKI67 protein] CTD PMID:31838054 lycopene multiple interactions EXP 6480464 Lycopene inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in increased expression of MKI67 protein] CTD PMID:33592256 MeIQx increases expression ISO RGD:1313525 6480464 2-amino-3 more ... CTD PMID:20816883 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of MKI67 protein] CTD PMID:19028472 melatonin decreases expression ISO RGD:1313525 6480464 Melatonin results in decreased expression of MKI67 mRNA, Melatonin results in decreased expression of MKI67 protein CTD PMID:21062352 methamphetamine decreases expression ISO RGD:1313525 6480464 Methamphetamine results in decreased expression of MKI67 mRNA CTD PMID:25290377 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of MKI67 mRNA CTD PMID:28619521 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of MKI67 protein CTD PMID:26558467 methotrexate decreases expression ISO RGD:1313525 6480464 Methotrexate results in decreased expression of MKI67 mRNA CTD PMID:24657277 methyl methanesulfonate increases expression ISO RGD:1313525 6480464 Methyl Methanesulfonate results in increased expression of MKI67 mRNA CTD PMID:23649840 methyl salicylate affects expression ISO RGD:1313526 6480464 methyl salicylate affects the expression of MKI67 mRNA CTD PMID:22302311 methyllycaconitine multiple interactions EXP 6480464 methyllycaconitine inhibits the reaction [[Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein] CTD PMID:29501575 methylmercury chloride increases expression ISO RGD:1313525 6480464 methylmercuric chloride results in increased expression of MKI67 mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride multiple interactions ISO RGD:1313525 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MKI67 mRNA CTD PMID:27188386 methylparaben increases expression ISO RGD:1313525 6480464 methylparaben results in increased expression of MKI67 mRNA, methylparaben results in increased expression of MKI67 protein CTD PMID:31745603 , PMID:35174924 methylseleninic acid decreases expression ISO RGD:1313525 6480464 methylselenic acid results in decreased expression of MKI67 mRNA CTD PMID:12517777 miconazole decreases expression ISO RGD:1313526 6480464 Miconazole results in decreased expression of MKI67 mRNA CTD PMID:27462272 microcystin-LR increases expression ISO RGD:1313526 6480464 cyanoginosin LR results in increased expression of MKI67 protein CTD PMID:28189720 , PMID:36115647 mifepristone decreases expression ISO RGD:1313525 6480464 Mifepristone results in decreased expression of MKI67 protein CTD PMID:18579510 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1313526 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO RGD:1313526 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA CTD PMID:31884101 monocrotaline multiple interactions ISO RGD:1313526 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein CTD PMID:21224054 monoethyl phthalate multiple interactions ISO RGD:1313526 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of MKI67 mRNA CTD PMID:31884101 N,N-bis(2-hydroxypropyl)nitrosamine multiple interactions EXP 6480464 [diisopropanolnitrosamine co-treated with Propylthiouracil] results in increased expression of MKI67 protein more ... CTD PMID:19497425 , PMID:22387750 N-acetyl-L-cysteine multiple interactions ISO RGD:1313525 6480464 Acetylcysteine inhibits the reaction [1 more ... CTD PMID:31518672 , PMID:32745510 N-butyl-N-(4-hydroxybutyl)nitrosamine multiple interactions EXP 6480464 [Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein more ... CTD PMID:29501575 N-methyl-4-phenylpyridinium increases expression ISO RGD:1313526 6480464 1-Methyl-4-phenylpyridinium results in increased expression of MKI67 protein CTD PMID:26558463 N-methyl-N-nitrosourea increases expression ISO RGD:1313526 6480464 Methylnitrosourea results in increased expression of MKI67 mRNA CTD PMID:25270620 N-nitrosodiethylamine increases expression ISO RGD:1313526 6480464 Diethylnitrosamine results in increased expression of MKI67 mRNA, Diethylnitrosamine results in increased expression of MKI67 protein CTD PMID:17854601 , PMID:17942915 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of MKI67 protein CTD PMID:24012840 N-nitrosodiethylamine increases expression ISO RGD:1313525 6480464 Diethylnitrosamine results in increased expression of MKI67 protein CTD PMID:21776270 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of MKI67 protein more ... CTD PMID:17393424 more ... N-nitrosodiethylamine multiple interactions ISO RGD:1313526 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 mRNA more ... CTD PMID:17854601 more ... N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of MKI67 mRNA CTD PMID:25380136 N-Nitrosopyrrolidine decreases expression ISO RGD:1313525 6480464 N-Nitrosopyrrolidine results in decreased expression of MKI67 mRNA CTD PMID:32234424 nickel atom increases expression ISO RGD:1313525 6480464 Nickel results in increased expression of MKI67 mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:1313525 6480464 nickel sulfate results in increased expression of MKI67 protein CTD PMID:21776270 niclosamide decreases expression ISO RGD:1313525 6480464 Niclosamide results in decreased expression of MKI67 mRNA CTD PMID:28284560 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of MKI67 protein CTD PMID:30959089 nicotine increases expression EXP 6480464 Nicotine results in increased expression of MKI67 protein CTD PMID:31678612 nicotine multiple interactions EXP 6480464 [Nicotine co-treated with Butylhydroxybutylnitrosamine] results in increased expression of MKI67 protein more ... CTD PMID:29501575 nimesulide multiple interactions EXP 6480464 nimesulide inhibits the reaction [[Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein] CTD PMID:22387750 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of MKI67 protein CTD PMID:31843527 nitrosobis(2-oxopropyl)amine increases expression EXP 6480464 nitrosobis(2-oxopropyl)amine results in increased expression of MKI67 protein CTD PMID:29877212 nonanoic acid affects expression ISO RGD:1313526 6480464 pelargonic acid affects the expression of MKI67 mRNA CTD PMID:22302311 Nonylphenol multiple interactions ISO RGD:1313525 6480464 fulvestrant inhibits the reaction [nonylphenol results in increased expression of MKI67 mRNA] CTD PMID:27260121 Nonylphenol increases expression ISO RGD:1313525 6480464 nonylphenol results in increased expression of MKI67 mRNA CTD PMID:27260121 NS-398 decreases expression ISO RGD:1313525 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of MKI67 mRNA CTD PMID:27318970 O-methyleugenol increases expression EXP 6480464 methyleugenol results in increased expression of MKI67 protein CTD PMID:23411599 , PMID:26011634 ochratoxin A decreases expression EXP 6480464 ochratoxin A results in decreased expression of MKI67 mRNA CTD PMID:21703336 ochratoxin A multiple interactions EXP 6480464 SHH protein modified form inhibits the reaction [ochratoxin A results in decreased expression of MKI67 mRNA] CTD PMID:21703336 Octicizer decreases expression ISO RGD:1313526 6480464 2-ethylhexyldiphenylphosphate results in decreased expression of MKI67 protein CTD PMID:35503735 Octicizer decreases expression ISO RGD:1313525 6480464 2-ethylhexyldiphenylphosphate results in decreased expression of MKI67 protein CTD PMID:35503735 omacetaxine mepesuccinate decreases expression ISO RGD:1313525 6480464 Homoharringtonine results in decreased expression of MKI67 protein CTD PMID:31726078 oridonin decreases expression ISO RGD:1313525 6480464 oridonin analog results in decreased expression of MKI67 protein CTD PMID:31594861 osimertinib multiple interactions ISO RGD:1313525 6480464 [ginsenoside Rg3 co-treated with osimertinib] results in decreased expression of MKI67 protein CTD PMID:31916386 osthole decreases expression ISO RGD:1313525 6480464 osthol results in decreased expression of MKI67 protein CTD PMID:31870840 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MKI67 mRNA CTD PMID:25729387 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of MKI67 mRNA CTD PMID:25729387 oxfendazole decreases expression EXP 6480464 oxfendazole results in decreased expression of MKI67 protein CTD PMID:26558467 ozone multiple interactions ISO RGD:1313526 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of MKI67 mRNA more ... CTD PMID:19555225 more ... ozone multiple interactions ISO RGD:1313525 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of MKI67 mRNA more ... CTD PMID:32699268 ozone decreases expression ISO RGD:1313526 6480464 Ozone results in decreased expression of MKI67 mRNA CTD PMID:24336422 palbociclib decreases expression ISO RGD:1313525 6480464 palbociclib results in decreased expression of MKI67 protein CTD PMID:15542782 more ... palbociclib multiple interactions ISO RGD:1313525 6480464 Doxorubicin promotes the reaction [palbociclib results in decreased expression of MKI67 protein], RB1 protein affects the reaction [palbociclib results in decreased expression of MKI67 protein] CTD PMID:22751436 , PMID:28620137 para-Cresidine increases expression EXP 6480464 cresidine results in increased expression of MKI67 protein CTD PMID:26338220 paracetamol decreases expression ISO RGD:1313526 6480464 Acetaminophen results in decreased expression of MKI67 mRNA CTD PMID:17942131 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MKI67 mRNA CTD PMID:33387578 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of MKI67 protein CTD PMID:26011634 paracetamol decreases expression ISO RGD:1313525 6480464 Acetaminophen results in decreased expression of MKI67 mRNA CTD PMID:29067470 paracetamol increases expression ISO RGD:1313525 6480464 Acetaminophen results in increased expression of MKI67 mRNA CTD PMID:22230336 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MKI67 protein CTD PMID:17431590 Paraoxon-methyl decreases expression ISO RGD:1313525 6480464 methylparaoxon results in decreased expression of MKI67 protein CTD PMID:18418871 parathion decreases expression ISO RGD:1313526 6480464 Parathion results in decreased expression of MKI67 protein CTD PMID:34813904 parathion-methyl decreases expression ISO RGD:1313525 6480464 Methyl Parathion results in decreased expression of MKI67 protein CTD PMID:18418871 PCB138 multiple interactions ISO RGD:1313526 6480464 [2 more ... CTD PMID:25510870 PD 0325901 multiple interactions ISO RGD:1313526 6480464 [mirdametinib affects the susceptibility to KRAS protein] affects the reaction [NVP-BKM120 results in decreased expression of MKI67 protein], mirdametinib inhibits the reaction [camostat results in increased expression of MKI67 protein] CTD PMID:24576621 , PMID:25104499 perfluorononanoic acid decreases expression ISO RGD:1313525 6480464 perfluoro-n-nonanoic acid results in decreased expression of MKI67 mRNA CTD PMID:32588087 perfluorooctanoic acid decreases expression ISO RGD:1313525 6480464 perfluorooctanoic acid results in decreased expression of MKI67 mRNA CTD PMID:36326898 perfluorooctanoic acid increases expression ISO RGD:1313526 6480464 perfluorooctanoic acid results in increased expression of MKI67 mRNA, perfluorooctanoic acid results in increased expression of MKI67 protein CTD PMID:36152675 perfluorooctanoic acid multiple interactions ISO RGD:1313526 6480464 Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein] CTD PMID:36152675 phenethyl isothiocyanate decreases expression EXP 6480464 phenethyl isothiocyanate results in decreased expression of MKI67 mRNA CTD PMID:17616710 phenethyl isothiocyanate increases expression EXP 6480464 phenethyl isothiocyanate results in increased expression of MKI67 protein CTD PMID:23535288 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of MKI67 mRNA CTD PMID:31324951 phenobarbital increases expression ISO RGD:1313526 6480464 Phenobarbital results in increased expression of MKI67 mRNA, Phenobarbital results in increased expression of MKI67 protein CTD PMID:19363144 more ... phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 protein CTD PMID:17651763 phenobarbital multiple interactions ISO RGD:1313526 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MKI67 mRNA more ... CTD PMID:19482888 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of MKI67 mRNA CTD PMID:25145657 phenytoin multiple interactions ISO RGD:1313526 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein CTD PMID:21224054 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of MKI67 protein CTD PMID:23535288 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of MKI67 protein CTD PMID:29877212 phloretin multiple interactions EXP 6480464 [Ruthenium binds to Phloretin] inhibits the reaction [9 more ... CTD PMID:34896434 phorbol 13-acetate 12-myristate increases expression ISO RGD:1313526 6480464 Tetradecanoylphorbol Acetate results in increased expression of MKI67 protein CTD PMID:22981962 phthalaldehyde affects expression ISO RGD:1313526 6480464 o-Phthalaldehyde affects the expression of MKI67 mRNA CTD PMID:22302311 phytoestrogen increases expression ISO RGD:1313525 6480464 Phytoestrogens results in increased expression of MKI67 mRNA CTD PMID:18310284 pirinixic acid multiple interactions ISO RGD:1313526 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of MKI67 mRNA] CTD PMID:17950772 pirinixic acid increases expression ISO RGD:1313526 6480464 pirinixic acid results in increased expression of MKI67 mRNA CTD PMID:17950772 , PMID:23811191 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of MKI67 mRNA CTD PMID:22484513 , PMID:32741897 piroxicam decreases expression ISO RGD:1313525 6480464 Piroxicam results in decreased expression of MKI67 mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1313526 6480464 Pregnenolone Carbonitrile results in increased expression of MKI67 mRNA CTD PMID:22698814 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1313526 6480464 Pregnenolone Carbonitrile results in decreased expression of MKI67 mRNA CTD PMID:28903501 pregnenolone 16alpha-carbonitrile multiple interactions ISO RGD:1313526 6480464 [1 more ... CTD PMID:23626729 progesterone increases expression ISO RGD:1313525 6480464 Progesterone results in increased expression of MKI67 mRNA CTD PMID:16888808 progesterone multiple interactions ISO RGD:1313525 6480464 Copper promotes the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein], Lead inhibits the reaction [[Progesterone co-treated with Estrogens] results in decreased expression of MKI67 protein] CTD PMID:32004626 progesterone multiple interactions EXP 6480464 [Estrogens co-treated with Progesterone] results in increased expression of MKI67 protein CTD PMID:16800253 progesterone affects expression ISO RGD:1313526 6480464 Progesterone affects the expression of MKI67 mRNA, Progesterone affects the expression of MKI67 protein CTD PMID:17251523 , PMID:22238285 progesterone decreases expression ISO RGD:1313526 6480464 Progesterone results in decreased expression of MKI67 mRNA CTD PMID:16966611 progesterone multiple interactions ISO RGD:1313526 6480464 Lithium Chloride inhibits the reaction [Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein]], Progesterone inhibits the reaction [Estradiol results in increased expression of MKI67 protein] CTD PMID:15845746 promethazine increases expression EXP 6480464 Promethazine results in increased expression of MKI67 protein CTD PMID:26558467 promethazine affects expression EXP 6480464 Promethazine affects the expression of MKI67 protein CTD PMID:26011634 propanal decreases expression ISO RGD:1313525 6480464 propionaldehyde results in decreased expression of MKI67 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:1313526 6480464 propiconazole results in increased expression of MKI67 mRNA, propiconazole results in increased expression of MKI67 protein CTD PMID:21278054 , PMID:22334560 propofol decreases expression ISO RGD:1313525 6480464 Propofol results in decreased expression of MKI67 protein CTD PMID:36207479 propranolol decreases expression ISO RGD:1313525 6480464 Propranolol results in decreased expression of MKI67 protein CTD PMID:31838054 propranolol multiple interactions ISO RGD:1313525 6480464 ANGPT2 protein inhibits the reaction [Propranolol results in decreased expression of MKI67 protein] CTD PMID:31838054 Ptaquiloside increases expression ISO RGD:1313526 6480464 ptaquiloside results in increased expression of MKI67 mRNA CTD PMID:22143989 quercetin multiple interactions ISO RGD:1313525 6480464 [Cisplatin co-treated with Quercetin] results in decreased expression of MKI67 protein, [Quercetin co-treated with Ascorbic Acid] results in increased expression of MKI67 mRNA CTD PMID:16082193 , PMID:17639512 quercetin affects phosphorylation ISO RGD:1313525 6480464 Quercetin affects the phosphorylation of MKI67 protein CTD PMID:35688186 quercetin decreases expression ISO RGD:1313526 6480464 Quercetin results in decreased expression of MKI67 protein CTD PMID:15067354 quercetin multiple interactions ISO RGD:1313526 6480464 Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein] CTD PMID:15067354 raloxifene decreases expression ISO RGD:1313525 6480464 Raloxifene Hydrochloride results in decreased expression of MKI67 protein CTD PMID:11535548 remdesivir decreases expression ISO RGD:1313525 6480464 remdesivir results in decreased expression of MKI67 protein CTD PMID:35417658 resveratrol increases expression ISO RGD:1313525 6480464 resveratrol results in increased expression of MKI67 mRNA CTD PMID:15149879 resveratrol multiple interactions EXP 6480464 Resveratrol inhibits the reaction [[lead acetate results in increased abundance of Lead] which results in decreased expression of MKI67 protein] CTD PMID:33978298 resveratrol decreases expression ISO RGD:1313526 6480464 resveratrol results in decreased expression of MKI67 protein CTD PMID:25505154 resveratrol decreases expression ISO RGD:1313525 6480464 Resveratrol results in decreased expression of MKI67 more ... CTD PMID:15767336 more ... resveratrol multiple interactions ISO RGD:1313525 6480464 [Coumestrol co-treated with Resveratrol] results in increased expression of MKI67 mRNA more ... CTD PMID:19167446 , PMID:26959057 resveratrol increases expression ISO RGD:1313526 6480464 resveratrol results in increased expression of MKI67 protein CTD PMID:22086758 rifampicin multiple interactions ISO RGD:1313526 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC gene mutant form] results in increased expression of MKI67 protein CTD PMID:21224054 rotenone affects expression ISO RGD:1313525 6480464 Rotenone affects the expression of MKI67 mRNA CTD PMID:33512557 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of MKI67 mRNA CTD PMID:28374803 rucaparib multiple interactions ISO RGD:1313525 6480464 [Irinotecan co-treated with rucaparib] results in decreased expression of MKI67 protein CTD PMID:30612311 ruthenium atom multiple interactions EXP 6480464 [Ruthenium binds to Phloretin] inhibits the reaction [9 more ... CTD PMID:34896434 SB 431542 multiple interactions ISO RGD:1313525 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 scutellarin multiple interactions ISO RGD:1313525 6480464 scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 mRNA], scutellarin inhibits the reaction [[cobaltous chloride co-treated with Glucose] results in increased expression of MKI67 protein] CTD PMID:25192544 Se-methyl-L-selenocysteine multiple interactions ISO RGD:1313525 6480464 [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein CTD PMID:18855134 Se-methyl-L-selenocysteine decreases expression ISO RGD:1313525 6480464 selenomethylselenocysteine results in decreased expression of MKI67 protein CTD PMID:18855134 Se-methylselenocysteine multiple interactions ISO RGD:1313525 6480464 [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein CTD PMID:18855134 Se-methylselenocysteine decreases expression ISO RGD:1313525 6480464 selenomethylselenocysteine results in decreased expression of MKI67 protein CTD PMID:18855134 senecionine increases expression EXP 6480464 senecionine results in increased expression of MKI67 mRNA CTD PMID:32419051 Senkirkine increases expression EXP 6480464 senkirkine results in increased expression of MKI67 mRNA CTD PMID:32419051 serpentine asbestos increases expression ISO RGD:1313526 6480464 Asbestos, Serpentine results in increased expression of MKI67 protein CTD PMID:17200189 serpentine asbestos multiple interactions ISO RGD:1313526 6480464 [MPO protein affects the susceptibility to Asbestos more ... CTD PMID:16266986 , PMID:17200189 sevoflurane increases expression ISO RGD:1313525 6480464 Sevoflurane results in increased expression of MKI67 protein CTD PMID:36207479 silicon dioxide increases expression ISO RGD:1313526 6480464 Silicon Dioxide results in increased expression of MKI67 mRNA CTD PMID:29341224 silicon dioxide decreases expression ISO RGD:1313525 6480464 Silicon Dioxide results in decreased expression of MKI67 protein CTD PMID:35288261 silver atom decreases expression ISO RGD:1313526 6480464 Silver results in decreased expression of MKI67 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1313526 6480464 Silver results in decreased expression of MKI67 mRNA CTD PMID:27131904 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of MKI67 protein CTD PMID:26577051 sirolimus decreases expression ISO RGD:1313525 6480464 Sirolimus results in decreased expression of MKI67 protein CTD PMID:19773376 sirolimus affects expression EXP 6480464 Sirolimus affects the expression of MKI67 mRNA CTD PMID:24971338 sirolimus multiple interactions ISO RGD:1313525 6480464 [ABT-737 co-treated with Sirolimus] results in decreased expression of MKI67 protein CTD PMID:19773376 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of MKI67 protein CTD PMID:21964460 sodium arsenite affects expression ISO RGD:1313525 6480464 sodium arsenite affects the expression of MKI67 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO RGD:1313525 6480464 sodium arsenite results in increased expression of MKI67 mRNA CTD PMID:29301061 sodium arsenite multiple interactions EXP 6480464 Tretinoin inhibits the reaction [sodium arsenite results in decreased expression of MKI67 protein] CTD PMID:21964460 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of MKI67 mRNA CTD PMID:22561333 sophoraflavanone B decreases expression EXP 6480464 8-prenylnaringenin results in decreased expression of MKI67 mRNA CTD PMID:26372666 succimer multiple interactions ISO RGD:1313526 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA CTD PMID:21641980 sulfadimethoxine multiple interactions EXP 6480464 [Sulfadimethoxine co-treated with diisopropanolnitrosamine] results in increased expression of MKI67 protein more ... CTD PMID:22387750 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of MKI67 protein CTD PMID:22387750 , PMID:23535288 sunitinib decreases expression ISO RGD:1313525 6480464 Sunitinib results in decreased expression of MKI67 mRNA CTD PMID:31533062 tamoxifen multiple interactions ISO RGD:1313525 6480464 [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein, [Tamoxifen co-treated with anastrozole] results in decreased expression of MKI67 protein CTD PMID:15767642 , PMID:18855134 tamoxifen decreases expression ISO RGD:1313525 6480464 Tamoxifen results in decreased expression of MKI67 protein CTD PMID:15767642 more ... tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of MKI67 protein CTD PMID:17219426 tamoxifen increases expression ISO RGD:1313525 6480464 Tamoxifen results in increased expression of MKI67 protein CTD PMID:12627041 tamoxifen decreases expression ISO RGD:1313526 6480464 Tamoxifen results in decreased expression of MKI67 protein CTD PMID:15067354 tamoxifen multiple interactions ISO RGD:1313526 6480464 Quercetin promotes the reaction [Tamoxifen results in decreased expression of MKI67 protein] CTD PMID:15067354 tebufenpyrad increases expression ISO RGD:1313525 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased expression of MKI67 mRNA CTD PMID:33512557 testosterone multiple interactions ISO RGD:1313525 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of MKI67 mRNA CTD PMID:21592394 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of MKI67 mRNA CTD PMID:32741896 testosterone decreases expression ISO RGD:1313525 6480464 Testosterone results in decreased expression of MKI67 mRNA CTD PMID:21592394 tetrachloromethane affects expression ISO RGD:1313526 6480464 Carbon Tetrachloride affects the expression of MKI67 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1313526 6480464 ATM protein inhibits the reaction [Carbon Tetrachloride results in increased expression of MKI67 protein] more ... CTD PMID:29987408 more ... tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MKI67 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1313526 6480464 Carbon Tetrachloride results in increased expression of MKI67 mRNA, Carbon Tetrachloride results in increased expression of MKI67 protein CTD PMID:27339419 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of MKI67 protein CTD PMID:16325526 tetraphene multiple interactions ISO RGD:1313526 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of MKI67 mRNA CTD PMID:27858113 thalidomide multiple interactions ISO RGD:1313525 6480464 [Azacitidine co-treated with Thalidomide] affects the expression of MKI67 mRNA CTD PMID:18720364 thalidomide decreases expression ISO RGD:1313525 6480464 Thalidomide results in decreased expression of MKI67 protein CTD PMID:34520751 thapsigargin decreases expression ISO RGD:1313525 6480464 Thapsigargin results in decreased expression of MKI67 mRNA CTD PMID:22378314 theobromine multiple interactions EXP 127229954 [Theobromine co-treated with Theanine] inhibits the reaction [1, 2-dimethylhydrazine increases expression Mki67 protein in the colon] RGD thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MKI67 mRNA, Thioacetamide results in increased expression of MKI67 protein CTD PMID:23411599 more ... thymoquinone decreases expression ISO RGD:1313525 6480464 thymoquinone results in decreased expression of MKI67 protein CTD PMID:31298468 titanium dioxide increases expression ISO RGD:1313526 6480464 titanium dioxide results in increased expression of MKI67 mRNA, titanium dioxide results in increased expression of MKI67 protein CTD PMID:23557971 , PMID:29128614 titanium dioxide increases expression ISO RGD:1313525 6480464 titanium dioxide results in increased expression of MKI67 mRNA CTD PMID:32224134 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of MKI67 mRNA CTD PMID:30012374 titanium dioxide multiple interactions ISO RGD:1313525 6480464 [Vitallium analog binds to titanium dioxide] which results in decreased expression of MKI67 mRNA CTD PMID:23825117 tolbutamide decreases expression EXP 6480464 Tolbutamide results in decreased expression of MKI67 protein CTD PMID:16718685 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MKI67 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of MKI67 mRNA CTD PMID:25729387 trabectedin increases expression EXP 6480464 trabectedin results in increased expression of MKI67 protein CTD PMID:12154027 tremolite asbestos increases expression ISO RGD:1313526 6480464 tremolite results in increased expression of MKI67 mRNA CTD PMID:29279043 triamcinolone acetonide decreases expression ISO RGD:1313525 6480464 Triamcinolone Acetonide results in decreased expression of MKI67 protein CTD PMID:16029572 Tributyltin oxide decreases expression ISO RGD:1313526 6480464 bis(tri-n-butyltin)oxide results in decreased expression of MKI67 mRNA CTD PMID:17942131 , PMID:18958704 trichloroethene increases expression ISO RGD:1313526 6480464 Trichloroethylene results in increased expression of MKI67 mRNA CTD PMID:25549359 , PMID:27618143 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of MKI67 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO RGD:1313525 6480464 trichostatin A results in decreased expression of MKI67 mRNA CTD PMID:23770000 trichostatin A affects expression ISO RGD:1313525 6480464 trichostatin A affects the expression of MKI67 mRNA CTD PMID:28542535 triclosan decreases expression ISO RGD:1313525 6480464 Triclosan results in decreased expression of MKI67 mRNA CTD PMID:30510588 trimellitic anhydride increases expression ISO RGD:1313526 6480464 trimellitic anhydride results in increased expression of MKI67 mRNA CTD PMID:19042947 trimellitic anhydride affects expression ISO RGD:1313526 6480464 trimellitic anhydride affects the expression of MKI67 mRNA CTD PMID:22302311 trimethyltin increases expression ISO RGD:1313526 6480464 trimethyltin results in increased expression of MKI67 mRNA CTD PMID:24002884 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of MKI67 mRNA CTD PMID:30589522 Triptolide decreases expression ISO RGD:1313525 6480464 triptolide results in decreased expression of MKI67 protein CTD PMID:24842335 triptonide increases expression ISO RGD:1313526 6480464 triptonide results in increased expression of MKI67 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:1313525 6480464 troglitazone results in decreased expression of MKI67 mRNA CTD PMID:19140230 troglitazone increases expression ISO RGD:1313525 6480464 troglitazone results in increased expression of MKI67 protein CTD PMID:10097144 trovafloxacin decreases expression ISO RGD:1313526 6480464 trovafloxacin results in decreased expression of MKI67 mRNA CTD PMID:35537566 tungsten decreases expression ISO RGD:1313526 6480464 Tungsten results in decreased expression of MKI67 mRNA CTD PMID:30912803 tunicamycin decreases expression ISO RGD:1313525 6480464 Tunicamycin results in decreased expression of MKI67 mRNA CTD PMID:22378314 urethane multiple interactions ISO RGD:1313526 6480464 CYP2E1 gene mutant form inhibits the reaction [Urethane affects the expression of MKI67 protein] CTD PMID:15790490 urethane affects expression ISO RGD:1313526 6480464 Urethane affects the expression of MKI67 protein CTD PMID:15790490 valproic acid affects expression ISO RGD:1313525 6480464 Valproic Acid affects the expression of MKI67 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1313525 6480464 Valproic Acid results in decreased expression of MKI67 mRNA CTD PMID:28001369 vanadium atom multiple interactions EXP 6480464 Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] CTD PMID:15565650 vanadium(0) multiple interactions EXP 6480464 Vanadium inhibits the reaction [2-Acetylaminofluorene results in increased expression of MKI67 protein] CTD PMID:15565650 vemurafenib multiple interactions ISO RGD:1313525 6480464 [Vemurafenib co-treated with 3, 5-bis((4-nitrophenyl)methylidene)-1-prop-2-enoylpiperidin-4-one] results in decreased expression of MKI67 protein CTD PMID:35648318 verteporfin multiple interactions ISO RGD:1313526 6480464 Verteporfin inhibits the reaction [perfluorooctanoic acid results in increased expression of MKI67 protein] CTD PMID:36152675 vincristine increases response to substance ISO RGD:1313525 6480464 MKI67 gene SNP results in increased susceptibility to Vincristine CTD PMID:20864405 vorinostat multiple interactions ISO RGD:1313525 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of MKI67 mRNA CTD PMID:27188386 wogonin decreases expression ISO RGD:1313525 6480464 wogonin results in decreased expression of MKI67 protein CTD PMID:32671444 xanthohumol decreases expression ISO RGD:1313525 6480464 xanthohumol results in decreased expression of MKI67 protein CTD PMID:35259468 Y-27632 multiple interactions ISO RGD:1313525 6480464 Y 27632 promotes the reaction [4-amino-2-trifluoromethyl-phenyl retinate results in decreased expression of MKI67 protein] CTD PMID:32417439 Y-27632 decreases expression ISO RGD:1313525 6480464 Y 27632 results in decreased expression of MKI67 protein CTD PMID:32417439 zearalenone increases expression ISO RGD:1313525 6480464 Zearalenone results in increased expression of MKI67 mRNA CTD PMID:28965971 zinc atom multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA CTD PMID:33549593 zinc atom multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA CTD PMID:23859036 zinc(0) multiple interactions EXP 6480464 [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA CTD PMID:23859036 zinc(0) multiple interactions ISO RGD:1313526 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of MKI67 mRNA CTD PMID:33549593 zingerone multiple interactions EXP 6480464 zingerone inhibits the reaction [1, 2-Dimethylhydrazine results in increased expression of MKI67 protein] CTD PMID:30720227 zoledronic acid multiple interactions ISO RGD:1313525 6480464 [zoledronic acid co-treated with Doxorubicin] results in decreased expression of MKI67 protein CTD PMID:18695136
